Evidence that the Lateral Septum is Involved in the Antidepressant-Like Effects of the Vasopressin V1b Receptor Antagonist, SSR149415
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Previous experiments with the first selective nonpeptide vasopressin V1b receptor antagonist SSR149415 ((2S, 4R)-1-[5-chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxyphenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidinecarboxamide) have shown that the drug elicits anxiolytic- and antidepressant-like effects following systemic administration. Extrahypothalamic V1b receptors have been suggested to be involved in these effects as evidenced by the findings that hypophysectomized rats were still sensitive to the antistress action of SSR149415. The first objective of the present work aimed at locating V1b receptors in the rat limbic brain using anti-V1b receptor immunohistochemistry. The immunolabeling revealed high densities of V1b receptors in the lateral septum, the amygdala, the bed nucleus of the stria terminalis, the hippocampal formation, and in several cortical areas. Since the lateral septum is well known to participate in the modulation of emotional processes, the second objective of this study went on to evaluate the behavioral effects of an infusion of SSR149415 into the lateral septum and to determine whether its behavioral effects are mediated by this structure. Animals were tested in models classically used for the screening of anxiolytics (ie the punished drinking and elevated plus-maze tests) and antidepressants (ie the forced-swimming test). Bilateral intraseptal infusion of SSR149415 (10 and 100 ng) produced a decrease in immobility t…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963 · cited 3×
“…role in limbic Figure 2 Schematic drawings of the localization of bilateral cannulae tips in the lateral septum of the rats treated with (a) control solution, (b) SSR149415 (1 ng), (c) SSR149415 (10 ng), or (d) SSR149415 (100 ng), according to the rat brain atlas of Paxinos and Watson (1998).”
Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
Pellow, S., Chopin, P., File, S. E., & Briley, M. (1985) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(85)90031-7 · Cited by 5,822 · cited 2×
“The procedure is based on that described by Pellow et al (1985).”
BackgroundMethodDepression: a new animal model sensitive to antidepressant treatments
PORSOLT, R. D., LE PICHON, M., & JALFRE, M. (1977) · Nature · doi:10.1038/266730a0 · Cited by 4,451 · cited 2×
“The procedure was a modification of that described by Porsolt et al (1977).”
BackgroundMethodA simple and reliable conflict procedure for testing anti-anxiety agents
Vogel, J. R., Beer, B., & Clody, D. E. (1971) · Psychopharmacologia · doi:10.1007/bf00403989 · Cited by 841 · cited 2×
“The procedure was a modification of that described by Vogel et al (1971).”
BackgroundMethodde Vries, G. J., & Buijs, R. M. (1983) · Brain Research · doi:10.1016/0006-8993(83)90855-7 · Cited by 565 · cited 1×
“& 2005 Nature Publishing Group All rights reserved 0893-133X/05 $30.00 www.neuropsychopharmacology.org nucleus of the stria terminalis (Caffe et al, 1987; De Vries and Buijs, 1983), which both project to the lateral septum.”
BackgroundInfluentialGriebel, G., Simiand, J., Serradeil-Le Gal, C., Wagnon, J., Pascal, M., Scatton, B., Maffrand, J.-P., & Soubrié, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092012099 · Cited by 471 · cited 6×
“In cases of a significant main effect, post hoc comparisons were performed with a Dunnett test.”
BackgroundMethodInfluentialSelf-citationAguilera, G., & Rabadan-Diehl, C. (2000) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00196-8 · Cited by 375 · cited 1×
“Vasopressin promotes pituitary adrenocorticotropin release through its ability to potentiate the stimulatory effects of corticotropin-releasing factor (Aguilera and Rabadan-Diehl, 2000).”
BackgroundLandgraf, R., Gerstberger, R., Montkowski, A., Probst, J., Wotjak, C., Holsboer, F., & Engelmann, M. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-06-04250.1995 · Cited by 341 · cited 1×
“Furthermore, these authors and others (Landgraf et al, 1995) have shown that the intraseptal application of nonselective V1 receptor antagonists or V1a receptor antisense produces anxiolytic-like effects in the elevated plus-maze in rats.”
BackgroundExtrapituitary expression of the rat V1b vasopressin receptor gene.
Lolait, S. J., O'Carroll, A. M., Mahan, L. C., Felder, C. C., Button, D. C., Young, W. S., Mezey, E., & Brownstein, M. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.6783 · Cited by 337 · cited 4×
“To date only a few studies have examined the expression of V1b receptor mRNA or protein in the rat brain (Lolait et al, 1995; Vaccari et al, 1998; Hernando et al, 2001).”
BackgroundMethodInfluentialVaccari, C., Lolait, S. J., & Ostrowski, N. L. (1998) · Endocrinology · doi:10.1210/endo.139.12.6382 · Cited by 308 · cited 2×
“To date only a few studies have examined the expression of V 1b receptor mRNA or protein in the rat brain (Lolait et al, 1995; Vaccari et al, 1998; Hernando et al, 2001).”
BackgroundResult
Research works printed but not linked: 1
- Wersinger SR, Christiansen M, O'Carroll A, Lolait SJ, Gold PW, Hu S et al (2003). Social aggression is reduced in vasopressin 1b receptor null mice but is elevated in vasopressin 1a receptor null mice. Program No. 838.14. 2003 Abstract Viewer/Itinerary Planner. Society for Neuroscience: Washington, DC.
Cited by
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Vasopressin: Behavioral roles of an “original” neuropeptide
Caldwell, H. K., Lee, H.-J., Macbeth, A. H., & Young, W. S. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.10.007 · Cited by 504
“Infusion of SSR149415 into the LS (Stemmelin et al., 2005) and into three nuclei of the amygdala also decreases immobility time in the forced swim task (Salome et al.”
BackgroundInfluentialVasopressin V1a and V1b Receptors: From Molecules to Physiological Systems
Koshimizu, T.-A., Nakamura, K., Egashira, N., Hiroyama, M., Nonoguchi, H., & Tanoue, A. (2012) · Physiological Reviews · doi:10.1152/physrev.00035.2011 · Cited by 407
“Bilateral intraseptal infusion of SSR149415 produced antidepressant-like effects but not anxiolytic-like effects (467), suggesting that the V1b receptors in the LS participate in the antidepressant- but not the anxiolytic-like action of SSR149415 in rats.”
BackgroundBielsky, I. F., Hu, S.-B., Ren, X., Terwilliger, E. F., & Young, L. J. (2005) · Neuron · doi:10.1016/j.neuron.2005.06.031 · Cited by 367
Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development
Koob, G. F. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000083 · Cited by 337
“…V1b receptorantagonist exertedanxiolytic- andantidepressantlike effects (Griebel et al., 2002), with a focus on sites of action in the basolateral amygdala, CeA, medial amygdala (Salomé et al., 2006), lateral septum (Stemmelin et al., 2005), and dorsal hippocampus (Engin and Treit, 2008).”
BackgroundYoung, W. S., Li, J., Wersinger, S. R., & Palkovits, M. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.08.040 · Cited by 222
“Pharmacological antagonism of the Avpr1b produces reduced anxiety and aggression (Griebel et al., 2002; Blanchard et al., 2005; Stemmelin et al., 2005).”
BackgroundBehavioral effects of neuropeptides in rodent models of depression and anxiety
Rotzinger, S., Lovejoy, D. A., & Tan, L. A. (2010) · Peptides · doi:10.1016/j.peptides.2009.12.015 · Cited by 211
Landgraf, R., Keßler, M. S., Bunck, M., Murgatroyd, C., Spengler, D., Zimbelmann, M., Nußbaumer, M., Czibere, L., Turck, C. W., Singewald, N., et al. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.07.003 · Cited by 199
Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?
Griebel, G., & Holsboer, F. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3702 · Cited by 194
Self-citationMcGregor, I. S., Callaghan, P. D., & Hunt, G. E. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.132 · Cited by 171
“elicits anxiolytic, antidepressant and prosocial effects (Griebel et al., 2002; Stemmelin et al., 2005; Shimazaki et al., 2006).”
BackgroundThe vasopressin system — From antidiuresis to psychopathology
Frank, E., & Landgraf, R. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.063 · Cited by 181
“Application of the V1B receptor antagonist SSR149415 into the lateral septum, however, had no effect on anxiety-related behavior, but revealed an antidepressant-like action (Stemmelin et al., 2005).”
BackgroundInnovative Approaches for the Treatment of Depression: Targeting the HPA Axis
THOMSON, F. J., & Craighead, M. W. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9518-3 · Cited by 171
“In contrast, injection of SSR149415 into either the lateral septum, the central, basolateral or the medial nuclei of the amygdala did induce an anti-depressant like effect in the rat forced-swim test [93, 177] suggesting that central V1b 700 Neurochem Res (2008) 33:691–707”
BackgroundWersinger, S. R., Caldwell, H. K., Christiansen, M., & Young, W. S. (2007) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2006.00294.x · Cited by 130
“Pharmacological antagonism of the Avpr1b also has behavioral consequences, producing reduced anxiety and aggression (Griebel et al. 2002; Blanchard et al. 2005; Stemmelin et al. 2005).”
BackgroundReduced ultrasonic vocalizations in vasopressin 1b knockout mice
Scattoni, M. L., McFarlane, H. G., Zhodzishsky, V., Caldwell, H. K., YOUNG, W., Ricceri, L., & Crawley, J. N. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.09.034 · Cited by 147
Oxytocin, vasopressin, and the motivational forces that drive social behaviors
Caldwell, H. K., & Albers, H. E. (2015) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2015_390 · Cited by 129
Neurohypophyseal hormones manipulation modulate social and anxiety-related behavior in zebrafish
Braida, D., Donzelli, A., Martucci, R., Capurro, V., Busnelli, M., Chini, B., & Sala, M. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2482-2 · Cited by 135
“Reduced anxiety was shown in mice treated with the selective AVP1b subtype receptor antagonist SSR149415 (Griebel et al. 2002; Blanchard et al. 2005; Stemmelin et al. 2005).”
BackgroundThe vasopressin Avpr1b receptor: Molecular and pharmacological studies
Roper, J., O'Carroll, A.-M., Young, W., & Lolait, S. (2011) · Stress · doi:10.3109/10253890.2010.512376 · Cited by 117
“Recently, SSR149415 has failed phase II clinical trials (Kirchhoff et al. 2009).”
BackgroundMethodInfluentialOpen questions in current models of antidepressant action
Tanti, A., & Belzung, C. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00585.x · Cited by 109
“The AD effects of the V1b antagonist occur via extra-hypothalamic mechanisms such as the lateral septum (Stemmelin et al., 2005) and different amygdala nuclei (Salome et al.”
BackgroundOxytocin and vasopressin: genetics and behavioral implications
Caldwell, H. K., & Young, W. S. (2006) · Handbook of Neurochemistry and Molecular Neurobiology · doi:10.1007/978-0-387-30381-9_25 · Cited by 113
Neural Substrates of Psychostimulant Withdrawal-Induced Anhedonia
D’Souza, M. S., & Markou, A. (2009) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_20 · Cited by 116
“Blockade of V1b receptors in the lateral septum and central nucleus of the amygdala have been shown to play an important role in mediating the antidepres- sant effects of this compound (Salome et al. 2006; Stemmelin et al. 2005).”
BackgroundCurrent investigational drugs for major depression
Kulkarni, S. K., & Dhir, A. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780902880850 · Cited by 122
“It has been shown that V1b receptors located in the lateral septum participate in the antidepressant- but not the anxiolytic-like action of SSR-149415 in rats [175].”
BackgroundOverview of cellular electrophysiological actions of vasopressin
Raggenbass, M. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.074 · Cited by 101
“Recently, the presence of vasopressin V1B receptors in some central structures has also been reported (Hernando et al., 2001; Lolait et al., 1995; Stemmelin et al., 2005; Vaccari et al., 1998; Young et al., 2006).”
BackgroundResultInfluentialEdwards, S., Guerrero, M., Ghoneim, O. M., Roberts, E., & Koob, G. F. (2012) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00291.x · Cited by 104
“This antibody has been extensively characterized in previous reports (Hurbin et al. 2002; Folny et al. 2003; Stemmelin et al. 2005).”
BackgroundThe vasopressin 1b receptor and the neural regulation of social behavior
Stevenson, E. L., & Caldwell, H. K. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2011.11.009 · Cited by 100
Zhang, L., & Hernández, V. S. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2012.10.010 · Cited by 96
Opposite effects of oxytocin and vasopressin on the emotional expression of the fear response
VIVIANI, D., & STOOP, R. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00418-4 · Cited by 96
Depression and antidepressants: molecular and cellular aspects
Lanni, C., Govoni, S. M., Lucchelli, A., & Boselli, C. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0055-x · Cited by 107
“gadala in the rat forced swimming test [147, 148].”
BackgroundSigns of attenuated depression-like behavior in vasopressin deficient Brattleboro rats
Mlynarik, M., Zelena, D., Bagdy, G., Makara, G. B., & Ježová, D. (2006) · Hormones and Behavior · doi:10.1016/j.yhbeh.2006.12.007 · Cited by 99
“, 2004), septum (Stemmelin et al., 2005) or into systemic circulation (Overstreet and Griebel, 2005) results in a shift towards active coping style represented by reduced floating.”
BackgroundDempster, E. L. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.10.1189 · Cited by 87
“More recently, a specific AVPR1b antagonist has been developed that shows antidepressant features in rats that parallel the effect of an established antidepressant, fluoxetine hydrochloride.(20,21) These lines of evidence provide substantial evidence to implicate AVPR1b in the chronic response to stress and in the pat…”
Vasopressin and Oxytocin in Control of the Cardiovascular System
Japundžić‐Žigon, N. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311020008 · Cited by 99
Engin, E., & Treit, D. (2008) · Progress in Neuro-psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.03.020 · Cited by 71
“…V1A antagonist into LS d(CH2)5-D-Tyr(Et)VAVP (1 ng) SPB (0) Everts and Koolhaas (1999) Vasopressin V1B antagonist into LS SSR149415 (10 ng, 100 ng) EPM (0) Stemmelin et al. (2005) Galanin into LS Galanin (1 nM) SPB (0) Echevarria et al. (2005) Galanin antagonist into LS M40 (0.2 nM, 2 nM)…”
InfluentialSalomé, N., Stemmelin, J., Cohen, C., & Griebel, G. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0424-1 · Cited by 89
“, septum and amygdala) in which vasopressin release could be stimulated by a variety of stressors (Ebner et al. 1999, 2002; Hernando et al. 2001; Stemmelin et al. 2005; Huber et al. 2005).”
BackgroundMethodInfluentialSelf-citationZhou, Y., Leri, F., Cummins, E., Hoeschele, M., & Kreek, M. J. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301419 · Cited by 89
“The central amygdala expresses relatively high levels of receptors for both AVP and oxytocin (Huber et al, 2005; Stemmelin et al, 2005).”
Muigg, P., Hoelzl, U., Palfrader, K., Neumann, I. D., Wigger, A., Landgraf, R., & Singewald, N. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.08.035 · Cited by 92
Involvement of vasopressin in affective disorders
Surget, A., & Belzung, C. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.065 · Cited by 90
Hodgson, R. A., Higgins, G. A., Guthrie, D. H., Lu, S. X., Pond, A. J., Mullins, D. E., Guzzi, M. F., Parker, E. M., & Varty, G. B. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.12.021 · Cited by 86
Griebel, G., Beeské, S., & Stahl, S. M. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12m07804 · Cited by 81
Self-citationShimazaki, T., Iijima, M., & Chaki, S. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.06.032 · Cited by 81
Schüle, C., Baghai, T. C., Eser, D., & Rupprecht, R. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.52 · Cited by 73
Sparapani, S., Millet-Boureima, C., Oliver, J., Mu, K., Hadavi, P., Kalostian, T., Ali, N., Avelar, C. M., Bardies, M., Barrow, B., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9010089 · Cited by 70
The role of the vasopressin 1b receptor in aggression and other social behaviours
CALDWELL, H., WERSINGER, S., & YOUNGIII, W. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00406-8 · Cited by 64
Interaction of Stress, Corticotropin-Releasing Factor, Arginine Vasopressin and Behaviour
Beurel, E., & Nemeroff, C. B. (2014) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2014_306 · Cited by 64
“…V1 receptors (SSR149415) that has shown anxiolytic, antidepressant and anti-stress effects (Griebel et al., 2002; Hodgson et al., 2007; Iijima and Chaki, 2007; Litvin et al., 2011; Overstreet and Griebel, 2005; Shimazaki et al., 2006; Simon et al., 2008; Stemmelin et al., 2005; Urani et al., 2011).”
BackgroundGriffante, C., Green, A., Curcuruto, O., Haslam, C. P., Dickinson, B. A., & Arban, R. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706383 · Cited by 60
“…(Griebel et al., 2002; 2003) suggests that the behavioural effects are not only British Journal of Pharmacology vol 146 (5) related to the antagonism at V1b receptors located in the pituitary, but also to the blockade of central V1b receptors (Griebel et al., 2002; Stemmelin et al., 2005).”
BackgroundHypothalamic vasopressin system regulation by maternal separation: Its impact on anxiety in rats
Zhang, L., Hernández, V. S., Liu, B., Medina‐Pizarro, M., Nava-Kopp, A. T., Irles, C., & Morales, M. A. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.03.046 · Cited by 65
“Amygdaloid nuclei present extensive AVP innervation with fibers coming from hypothalamic sources (Buijs, 1978; Sofroniew, 1980), and recent immunohistochemical studies have demonstrated the presence of V1b receptors throughout the entire amygdalar complex: central, medial and basolateral divisions (Hernando et al., 20…”
BackgroundVasopressin & Oxytocin in Control of the Cardiovascular System: An Updated Review
Japundžić‐Žigon, N., Lozić, M., Šarenac, O., & Murphy, D. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666190717150501 · Cited by 67
“V1bR were also found in the limbic system where they exert anxiogenic effects [50-54].”
BackgroundOverstreet, D. H., & Griebel, G. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.07.021 · Cited by 60
“, 2002), lateral septum (Stemmelin et al., 2005), and/or paraventricular nucleus of the hypothalamus (Wotjak et al.”
BackgroundSelf-citationAulinas, A., Plessow, F., Asanza, E., Silva, L., Marengi, D. A., Fan, W., Abedi, P., Verbalis, J., Tritos, N. A., Nachtigall, L., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02608 · Cited by 54
Caldwell, H. K. (2012) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4614-1704-0_12 · Cited by 58
Divergent regulation of distinct glucocorticoid systems in alcohol dependence
Edwards, S., Little, H. J., Richardson, H. N., & Vendruscolo, L. F. (2015) · Alcohol · doi:10.1016/j.alcohol.2015.04.004 · Cited by 56
Vasopressin Antagonists as Anxiolytics and Antidepressants: Recent Developments
Simon, N., Guillon, C., Fabio, K., Heindel, N., Lu, S.-F., Miller, M., Ferris, C., Brownstein, M., Garripa, C., & Koppel, G. (2008) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488908784534586 · Cited by 51
The Role of Serotonin, Vasopressin, and Serotonin/Vasopressin Interactions in Aggressive Behavior
Morrison, T. R., & Melloni, R. H. (2014) · Current topics in behavioral neurosciences · doi:10.1007/7854_2014_283 · Cited by 57
“…V1A receptor influences maternal care, mate-bonding, and social recognition (Bielsky et al. 2004; Pitkow et al. 2001; Wersinger et al. 2002) while the V1B receptor is associated with depression, the stress response, and anxiety (Griebel et al. 2012, 2003; Salomé et al. 2006; Stemmelin et al. 2005).”
BackgroundLouis, C., Cohen, C., Depoortère, R., & Griebel, G. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301036 · Cited by 55
“…of the HPA axis by SSR149415 and SSR125543 may account for these effects is challenged by findings indicating that extra-hypothalamic structures might also be involved in the antidepressant-like effects of CRF1 receptor antagonists and SSR149415 (Griebel et al, 2002b; Stemmelin et al, 2005).”
BackgroundSelf-citationStewart, L. Q., Roper, J. A., Young, W. S., O’Carroll, A. ‐., & Lolait, S. J. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01704.x · Cited by 48
Are neuropeptides relevant for the mechanism of action of SSRIs?
Gołyszny, M., & Obuchowicz, E. (2019) · Neuropeptides · doi:10.1016/j.npep.2019.02.002 · Cited by 47
Arban, R., Bianchi, F., Buson, A., Cremonesi, S., Fabio, R. D., Gentile, G., Micheli, F., Pasquarello, A., Pozzan, A., Tarsi, L., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.07.037 · Cited by 44
Social Context, Stress, Neuropsychiatric Disorders, and the Vasopressin 1b Receptor
Caldwell, H. K., Aulino, E. A., Rodriguez, K. M., Witchey, S. K., & Yaw, A. M. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00567 · Cited by 40
“, 2011), while the Avpr1b in the LS is suspected to be involved in depressive states (Stemmelin et al., 2005).”
BackgroundMethodInfluentialThe acute intoxicating effects of ethanol are not dependent on the vasopressin 1a or 1b receptors
Caldwell, H. K., Stewart, J., Wiedholz, L. M., Millstein, R. A., Iacangelo, A. L., Holmes, A., Young, W. S., & Wersinger, S. R. (2006) · Neuropeptides · doi:10.1016/j.npep.2006.08.001 · Cited by 44
Non-Monoamine-Based Approach for the Treatment of Depression and Anxiety Disorders
Chaki, S., Okubo, T., & Sekiguchi, Y. (2006) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488906775245318 · Cited by 39
Neuropeptide and Sigma Receptors as Novel Therapeutic Targets for the Pharmacotherapy of Depression
Paschos, K. A., Veletza, S. V., & Chatzaki, Ε. (2009) · CNS Drugs · doi:10.2165/11310830-000000000-00000 · Cited by 43
“Preclinical data indicated that the administration of nonpeptide vasopressin receptor antagonists, such as the V1B receptor antagonist SSR149415 ((2S,4R)1-[5-chloro-1-[(2,4-dimethoxyphenyl)-sulfonyl]3-(2-methoxyphenyl)-2-oxo-2,3-dihydro-1H-indol3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidinecarboxamide) [figure 7], reduced…”
BackgroundEngin, E., & Treit, D. (2008) · Neuropeptides · doi:10.1016/j.npep.2008.04.004 · Cited by 38
Gal, C. S.-L., Raufaste, D., Derick, S., Blankenstein, J., Allen, J., Pouzet, B., Pascal, M., Wagnon, J., & Ventura, M. A. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00062.2007 · Cited by 35
“Recently, we confirmed the antidepressant-like effects of SSR-149415 in the forcedswimming test following specific intracerebroventricular injections in the lateral septum, giving further convincing evidence of the presence of V1bR in the rat central nervous system (CNS) and showing a central component in the mechanis…”
BackgroundVasopressin and alcohol: a multifaceted relationship
Harper, K. M., Knapp, D. J., Criswell, H. E., & Breese, G. R. (2018) · Psychopharmacology · doi:10.1007/s00213-018-5099-x · Cited by 38
“…administered via an osmotic minipump (Landgraf et al. 1995) in the septum decreased anxiety-related behaviors on the elevated plus maze, but microinjection of the V1b antagonist into the septum had no effect on the elevated plus maze or the punished drinking conflict test (Stemmelin et al. 2005).”
Vasopressin V1B receptor antagonists as potential antidepressants
Chaki, S. (2021) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyab013 · Cited by 34
Ding, Y., Wei, Z., Yan, H., & Guo, W. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.732157 · Cited by 34
“Early animal studies had found that vasopressin-containing neurons were distributed in limbic areas and that their messenger RNA expression was increased by chronic stress (Rabadan-Diehl et al., 1995; Hernando et al., 2001; Stemmelin et al., 2005).”
BackgroundWu, L., Liu, Y., Yan, C., Pan, Y., Su, J., & Wu, W.-K. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/6784689 · Cited by 34
“in the paraventricular nucleus, AVP reactivity in the pituitary, and AVP mRNA expression in the supraoptic nucleus in depressed patients [27, 28], which also suggests that AVP changes in the paraventricular nucleus and supraoptic nucleus may be the basis for the onset of depression.”
BackgroundRamos, A. T., Troncone, L. R. P., & Tufik, S. (2006) · Neuroendocrinology · doi:10.1159/000097587 · Cited by 33
Allaman‐Exertier, G., Reymond‐Marron, I., Tribollet, E., & Raggenbass, M. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05866.x · Cited by 31
“In particular, some evidence has been obtained suggesting that V1B receptors may be present in the lateral septal area and that blockade of these receptors could exert some antidepressant effect (Stemmelin et al., 2005).”
BackgroundInfluentialUrani, A., Philbert, J., Cohen, C., & Griebel, G. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.02.019 · Cited by 35
“However, their action might, alternatively or in addition, involve extra-HPA axis sites since both CRF1 and V1b receptors are found in brain structures associated with the integration and transductionof stressful stimuli, such as the amygdala, the lateral septum, and thehippocampus, and in caseof SSR149415havebeen sho…”
BackgroundSelf-citationStojicic, S., Milutinović‐Smiljanić, S., Šarenac, O., Milosavljević, S., Paton, J. F. R., Murphy, D., & Japundžić‐Žigon, N. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.12.013 · Cited by 35
“…application of the V1b antagonist (SSR149415) has been shown to induce antidepressive behaviour (Griebel et al., 2002; Serradeil-Le Gal et al., 2005; Stemmelin et al., 2005), while down regulation of V1a receptors in the septum was also reported to reduce anxiety (Landgraf et al., 1995).”
BackgroundRamos‐Miguel, A., Esteban, S., & García-Sevilla, J. A. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.08.005 · Cited by 29
“DMSO did not alter the motor activity (Einat et al., 2003; present study) or other behavioral tests in rats (Stemmelin et al., 2005).”
Cudnoch‐Jędrzejewska, A., Szczepanska‐Sadowska, E. K., Dobruch, J. T., Gomolka, R. S., & Puchalska, L. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00543.2009 · Cited by 30
Bayerl, D. S., Kaczmarek, V., Jurek, B., van den Burg, E. H., Neumann, I. D., Gaßner, B. M., Klampfl, S. M., & Bosch, O. J. (2015) · Hormones and Behavior · doi:10.1016/j.yhbeh.2015.12.003 · Cited by 32
“The concentration was chosen based on previous studies (Bayerl et al., 2014; Salomé et al., 2006; Stemmelin et al., 2005); binding of the V1bR antagonist to the structurally similar oxytocin and V1a receptor is rather unlikely as SSR149415 binds with high specificity to the rat V1bR (Griebel et al.”
Kamiya, M., Sabia, H. D., Marella, J., Fava, M., Nemeroff, C. B., Umeuchi, H., Iijima, M., Chaki, S., & Nishino, I. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.05.017 · Cited by 28
Neurobiological aspects of pain in the context of alcohol use disorder
Cucinello‐Ragland, J. A., & Edwards, S. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.09.001 · Cited by 33
Kanes, S., Dennie, L., & Perera, P. (2023) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s402831 · Cited by 31
Bayerl, D. S., Klampfl, S. M., & Bosch, O. J. (2014) · Journal of Neuroendocrinology · doi:10.1111/jne.12226 · Cited by 30
Synthesis of [11C]SSR149415 and preliminary imaging studies using positron emission tomography
Schönberger, M., Leggett, C. S., Kim, S. W., & Hooker, J. M. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.03.108 · Cited by 25
Examining the Role of Vasopressin in the Modulation of Parental and Sexual Behaviors
Zimmermann-Peruzatto, J. M., Lazzari, V. M., de Moura, A. C., Almeida, S., & Giovenardi, M. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00130 · Cited by 25
“Pharmacological studies have shown that VP administration improves social recognition in both sexes (58, 63).”
BackgroundBalázsfi, D., Pintér, O., Klausz, B., Kovács, K., Fodor, A., Török, B., Engelmann, M., & Zelena, D. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.09.011 · Cited by 23
“In more remote brain areas AVP acts as neuromodulator and neurotransmitter via local V1 receptors (Johnson et al., 1993, Lolait et al., 1995, Vaccari et al., 1998, Hernando et al., 2001, Stemmelin et al., 2005).”
BackgroundHarper, K. M., Knapp, D. J., Butler, R. K., Cook, C. A., Criswell, H. E., Stuber, G. D., & Breese, G. R. (2019) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14163 · Cited by 25
Vasopressinergic control of stress-related behavior: studies in Brattleboro rats
Csikota, P., Fodor, A., Balázsfi, D., Pintér, O., Mizukami, H., Weger, S., Heilbronn, R., Engelmann, M., & Zelena, D. (2016) · Stress · doi:10.1080/10253890.2016.1183117 · Cited by 21
“To measure innate anxiety, three different paradigms were used: (1) The elevated plus-maze test (EPM test) was introduced as an apparatus for testing innate anxiety in laboratory rodents (Stemmelin et al., 2005).”
BackgroundMethodInfluentialOxytocin, vasopressin and their interplay with gonadal steroids
Dhakar, M. B., Stevenson, E. L., & Caldwell, H. K. (2013) · Oxytocin, Vasopressin and Related Peptides in the Regulation of Behavior · doi:10.1017/cbo9781139017855.003 · Cited by 20
Combination therapy with neuropeptides for the treatment of anxiety disorder
Gupta, P. R., & Prabhavalkar, K. S. (2021) · Neuropeptides · doi:10.1016/j.npep.2021.102127 · Cited by 21
Agorastos, A., Sommer, A., Heinig, A., Wiedemann, K., & Demiralay, C. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00453 · Cited by 20
Hernández‐Pérez, O. R., Crespo‐Ramírez, M., Ferrer, Y. C., Anías-Calderón, J., Zhang, L., Roldán-Roldán, G., Aguilar‐Roblero, R. A., Borroto‐Escuela, D. O., Fuxé, K., & de la Mora, M. P. (2018) · Psychopharmacology · doi:10.1007/s00213-017-4817-0 · Cited by 19
Reymond‐Marron, I., Tribollet, E., & Raggenbass, M. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05038.x · Cited by 19
“The V1b receptor antagonist SSR149415 appears to exert anxiolytic- and antidepressantlike effects (Griebel et al., 2002; Stemmelin et al., 2005).”
BackgroundVasopressin and vasopressin receptors in brain edema
Zeynalov, E., Jones, S. M., & Elliott, J. P. (2020) · Vitamins and hormones · doi:10.1016/bs.vh.2019.08.015 · Cited by 18
Hernández, V. S., Ruiz‐Velasco, S., & Zhang, L. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.09.002 · Cited by 16
The Role of Vasopressin in Anxiety and Depression
Morales‐Medina, J. C., Witchey, S. K., & Caldwell, H. K. (2016) · Springer eBooks · doi:10.1007/978-81-322-2803-5_40 · Cited by 14
Chapter 4.1 Peptide receptor ligands to treat anxiety disorders
Steckler, T. (2008) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(07)00010-0 · Cited by 13
V1b Receptors: New Probes for Therapy
Arban, R. (2007) · Endocrinology · doi:10.1210/en.2007-0735 · Cited by 8
Landgraf, R., & Holsboer, F. (2005) · Drug Development Research · doi:10.1002/ddr.20022 · Cited by 10
Stojicic, S., Milutinović‐Smiljanić, S., Šarenac, O., Živković, S., & Japundžić‐Žigon, N. (2006) · Biomedizinische Technik/Biomedical Engineering · doi:10.1515/bmt.2006.053 · Cited by 7
Belyakova, A. S., Sinjushin, A. A., Voskresenskaya, O. G., Kamensky, A. A., & Golubovich, V. P. (2015) · Neurochemical Journal · doi:10.1134/s1819712415030034 · Cited by 6
The roles of vasopressin and oxytocin in aggression
Pagani, J. H., Wersinger, S. R., & Young, W. S. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139017855.014 · Cited by 5
The Role of Vasopressin in Anxiety: What Can We Learn From Studying Ultrasonic Vocalization?
Zelena, D. (2018) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-809600-0.00041-x · Cited by 3
Verbalis, J. G. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00049-8 · Cited by 3
Belyakova, A. S., Voskresenskaya, O. G., Kamensky, A. A., & Golubovich, V. P. (2012) · Moscow University Biological Sciences Bulletin · doi:10.3103/s0096392512010026 · Cited by 3
Therapeutic potential of vasopressin in the treatment of neurological disorders
Mishra, S., Grewal, J., Wal, P., Bhivshet, G. U., Tripathi, A. K., & Walia, V. (2024) · Peptides · doi:10.1016/j.peptides.2024.171166 · Cited by 5
Ślusarz, M. J. (2024) · Biopolymers · doi:10.1002/bip.23627 · Cited by 2
“Although pituitary V1bR was recognized to be the main target of nelivaptan action also V1bR located in the CNS are supposed to be engaged in exerting the antidepressant effects [28, 29].”
Metadata
- Authors
- Stemmelin, J., Lukovic, L., Salome, N., & Griebel, G.
- Affiliations
- Sanofi (France) (FR)
- Corresponding author
- Griebel, Guy
- ORCID
- Griebel, Guy
- Venue
- Neuropsychopharmacology
- Published
- 2004-09-15
- Volume
- 30
- Issue
- 1
- Pages
- 35-42
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2105602144
- Cited by
- 112
- References
- 30
- Citations by year
- 2026: 1 · 2024: 3 · 2023: 1 · 2021: 4 · 2020: 5 · 2019: 4 · 2018: 4 · 2017: 1 · 2016: 3 · 2015: 5 · 2014: 5 · 2013: 7 · 2012: 10
- FWCI
- 3.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Keywords
- vasopressin V1b receptor, lateral septum, antidepressant-like effects, anxiolytic-like effects, forced swim test, elevated plus maze, limbic system, emotional modulation
- MeSH terms
- Animals, Antidepressive Agents, Anxiety, Brain, Brain Chemistry, Drinking, Immunohistochemistry, Indoles, Functional Laterality, Male, Microinjections, Pyrrolidines, Swimming, Neostriatum, Rats, Sprague-Dawley, Septum of Brain, Rats, Antidiuretic Hormone Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.